MHBC Intervention Trial
Phase 1
20
about 2 years
18–65
1 site in CT
What this study is about
This trial is testing a new treatment for weight loss and smoking cessation in people getting bariatric surgery. The treatment includes medication (Naltrexone + Bupropion) and behavior therapy, and it lasts 729 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Cognitive-Behavioral Therapy
- 2.Take Bupropion HCl Extended Release
- 3.Take Naltrexone Hydrochloride
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
bupropion, Antidotes, Deterrents, and Toxicologic Agents (Opioid Antagonists)
oral (Oral Tablet)
Primary: Percent weight change
Secondary: Depressive symptomatology, as measured by the Patient Health Questionnaire-9
therapy
Endocrinology